![BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.onc.1206082/MediaObjects/41388_2002_Article_BF1206082_Fig1_HTML.jpg)
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene
![Comparing the mode of action of BCR-ABL and imatinib in CML pathogenesis. | Download Scientific Diagram Comparing the mode of action of BCR-ABL and imatinib in CML pathogenesis. | Download Scientific Diagram](https://www.researchgate.net/publication/6517125/figure/fig3/AS:601624380702726@1520449838287/Comparing-the-mode-of-action-of-BCR-ABL-and-imatinib-in-CML-pathogenesis.png)
Comparing the mode of action of BCR-ABL and imatinib in CML pathogenesis. | Download Scientific Diagram
![IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells](https://www.mdpi.com/ijms/ijms-18-00537/article_deploy/html/images/ijms-18-00537-g006-550.jpg)
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
![BCR-ABL Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests | JCO Oncology Practice BCR-ABL Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests | JCO Oncology Practice](https://ascopubs.org/cms/10.1200/JOP.2016.014449/asset/images/large/jop.2016.014449t1.jpeg)
BCR-ABL Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests | JCO Oncology Practice
![BCR-ABL Signaling in CML: BCR-ABL oncoprotein causes the recruitment of... | Download Scientific Diagram BCR-ABL Signaling in CML: BCR-ABL oncoprotein causes the recruitment of... | Download Scientific Diagram](https://www.researchgate.net/publication/233987582/figure/fig1/AS:300001466044416@1448537331324/BCR-ABL-Signaling-in-CML-BCR-ABL-oncoprotein-causes-the-recruitment-of-growth-regulators.png)
BCR-ABL Signaling in CML: BCR-ABL oncoprotein causes the recruitment of... | Download Scientific Diagram
![BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.onc.1206082/MediaObjects/41388_2002_Article_BF1206082_Fig4_HTML.jpg)
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene
![Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy | Molecular Cancer | Full Text Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy | Molecular Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12943-018-0780-6/MediaObjects/12943_2018_780_Fig5_HTML.gif)
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy | Molecular Cancer | Full Text
![Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review](https://www.mdpi.com/hematolrep/hematolrep-14-00008/article_deploy/html/images/hematolrep-14-00008-g001.png)
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g001.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Paper of the Month: Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity | OHSU News Paper of the Month: Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity | OHSU News](https://news.ohsu.edu/_ir/296/201608/paper-figure-22211.gif)
Paper of the Month: Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity | OHSU News
Vela Diagnostics - Do you know what causes Chronic Myeloid Leukemia (#CML), a #cancer that starts in the bone marrow and invades the blood? A #translocation between chromosomes 9 and 22 forms
![Next-Generation Sequencing for BCR-ABL Mutations in Patients Receiving First- and Second-Line Tyrosine Kinase Inhibitors for CML | Research To Practice Next-Generation Sequencing for BCR-ABL Mutations in Patients Receiving First- and Second-Line Tyrosine Kinase Inhibitors for CML | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASH2016/4/17/Slide2.jpg)
Next-Generation Sequencing for BCR-ABL Mutations in Patients Receiving First- and Second-Line Tyrosine Kinase Inhibitors for CML | Research To Practice
![Chronic myeloid leukemia: cytogenetics and molecular biology's part in the comprehension and management of the pathology and treatment evolution | Egyptian Journal of Medical Human Genetics | Full Text Chronic myeloid leukemia: cytogenetics and molecular biology's part in the comprehension and management of the pathology and treatment evolution | Egyptian Journal of Medical Human Genetics | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs43042-022-00248-2/MediaObjects/43042_2022_248_Fig1_HTML.png)